Abstract: Gestational diabetes(GDM) is one of the most common complications during pregnancy, which seriously threatens the health of mothers and infants. Therefore, blood glucose monitoring and control during pregnancy are essential. Glycated albumin(GA) is the indicator of short-term glycemic control that reflects the mean blood glucose level in prior 2-3 weeks. Compared with other methods monitoring blood glucose, the application of GA in GDM is more advantageous. GA can be used as a good indicator for monitoring blood glucose during pregnancy and predict complications for mother and infants. However, there are few studies of GA in pregnant women, and the reference range of its normal value in pregnant women has not been defined. This review is about the progress in research on glycosylated albumin in gestational diabetes.